Pathophysiology & Clinical Findings of the Disease
Review the lab findings and decide if the diagnosis is Type 2 or Type 1 Diabetes Mellitus.
Explain the pathophysiology associated with your chosen diagnosis
Identify at least three subjective findings from the case which support the chosen diagnosis.
Identify at least three objective findings from the case which support the chosen diagnosis.
Management of the Disease
*Utilize the required Clinical Practice Guideline (CPG) to support your treatment recommendations.
Identify two (2) "Evidence A" recommended medication classes for the treatment of this condition and provide an example (drug name) for each.
Describe the mechanism of action for each of the medication classes identified above.
Identify two (2) "Evidence A" recommended non-pharmacological treatment options for this patient.
Utilizes the required Clinical Practice Guideline (CPG) to support the chosen treatment recommendations
Sample Solution
Hypothetical Case Scenario
Assuming the following lab results:
- Fasting blood glucose: 250 mg/dL
- Hemoglobin A1c: 9%
- Negative C-peptide level
- Positive GAD antibodies
- Polyuria: Increased urination due to excessive glucose in the blood.
- Polydipsia: Increased thirst due to dehydration caused by excessive urination.
- Polyphagia: Increased appetite due to cellular starvation despite increased food intake.
- Hyperglycemia: Fasting blood glucose of 250 mg/dL.
- Poor glycemic control: Hemoglobin A1c of 9%.
- Autoimmune markers: Positive GAD antibodies.
- Insulin therapy: The cornerstone of type 1 diabetes management.
- Rapid-acting insulin (e.g., lispro, aspart): Mimics the body's natural insulin response to meals.
- Long-acting insulin (e.g., glargine, detemir): Provides basal insulin coverage throughout the day.
- Self-monitoring of blood glucose (SMBG): Regular blood glucose monitoring to adjust insulin doses and lifestyle.
- Carbohydrate counting: Matching insulin doses to carbohydrate intake to maintain blood glucose control.